Dec. 30 at 12:30 PM
$NVO's oral obesity pill just got FDA approval — a game changer in weight-loss drugs! 💊
🌟 First FDA-approved oral GLP-1 pill for chronic weight management in the U.S.
💰 Priced at
$149/month, more accessible than injectables
📈 Participants lost 16.6% body weight in trials
Discover why
$OZEM,
$THNR, and
$PPH might be the smarter play here 👉 https://www.zacks.com/stock/news/2809629/the-obesity-pill-rush-healthcare-etfs-to-gain-as-fda-nods-to-novo-drug?cid=sm-stocktwits-2-2809629-body-26689&ADID=SYND_STOCKTWITS_TWEET_2_2809629_BODY_26689